197 related articles for article (PubMed ID: 12021957)
21. The myotonic dystrophies: molecular, clinical, and therapeutic challenges.
Udd B; Krahe R
Lancet Neurol; 2012 Oct; 11(10):891-905. PubMed ID: 22995693
[TBL] [Abstract][Full Text] [Related]
22. The myotonic dystrophies: diagnosis and management.
Turner C; Hilton-Jones D
J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):358-67. PubMed ID: 20176601
[TBL] [Abstract][Full Text] [Related]
23. Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.
Dabby R; Sadeh M; Herman O; Leibou L; Kremer E; Mordechai S; Watemberg N; Frand J
Isr Med Assoc J; 2011 Dec; 13(12):745-7. PubMed ID: 22332444
[TBL] [Abstract][Full Text] [Related]
24. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2.
Vihola A; Bassez G; Meola G; Zhang S; Haapasalo H; Paetau A; Mancinelli E; Rouche A; Hogrel JY; Laforêt P; Maisonobe T; Pellissier JF; Krahe R; Eymard B; Udd B
Neurology; 2003 Jun; 60(11):1854-7. PubMed ID: 12796551
[TBL] [Abstract][Full Text] [Related]
25. Myotonic dystrophies.
Meola G
Curr Opin Neurol; 2000 Oct; 13(5):519-25. PubMed ID: 11073357
[TBL] [Abstract][Full Text] [Related]
26. Proximal myotonic myopathy (PROMM) presenting as myotonia during pregnancy.
Newman B; Meola G; O'Donovan DG; Schapira AH; Kingston H
Neuromuscul Disord; 1999 May; 9(3):144-9. PubMed ID: 10382907
[TBL] [Abstract][Full Text] [Related]
27. [Myotonic dystrophy (DM/Curschmann-Steinert disease) and proximal myotonic myopathy (PROMM/Ricker syndrome). Myotonic muscle diseases with multisystemic manifestations].
Schneider C; Reiners K; Toyka KV
Nervenarzt; 2001 Aug; 72(8):618-24. PubMed ID: 11519202
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal in vivo muscle function analysis of the DMSXL mouse model of myotonic dystrophy type 1.
Decostre V; Vignaud A; Matot B; Huguet A; Ledoux I; Bertil E; Gjata B; Carlier PG; Gourdon G; Hogrel JY
Neuromuscul Disord; 2013 Dec; 23(12):1016-25. PubMed ID: 24139022
[TBL] [Abstract][Full Text] [Related]
29. Painful camptocormia: the relevance of shaking your patient's hand.
Dupeyron A; Stober N; Gelis A; Castelnovo G; Labauge P; Pélissier J
Eur Spine J; 2010 Jul; 19 Suppl 2(Suppl 2):S87-90. PubMed ID: 19590905
[TBL] [Abstract][Full Text] [Related]
30. Intergenerational changes of CTG repeat depending on the sex of the transmitting parent in myotonic dystrophy type 1.
Rakocević-Stojanović V; Savić D; Pavlović S; Lavrnić D; Stević Z; Basta I; Romac S; Apostolski S
Eur J Neurol; 2005 Mar; 12(3):236-7. PubMed ID: 15693817
[No Abstract] [Full Text] [Related]
31. [Myotonic dystrophy: magnetic resonance tomography and clinico-genetic correlations].
Damian MS; Koch MC; Bachmann G; Schilling G; Fach B; Stöppler S; Trittmacher S; Dorndorf W
Nervenarzt; 1995 Jun; 66(6):438-44. PubMed ID: 7637829
[TBL] [Abstract][Full Text] [Related]
32. Muscle phenotype in patients with myotonic dystrophy type 1.
Andersen G; Ørngreen MC; Preisler N; Colding-Jørgensen E; Clausen T; Duno M; Jeppesen TD; Vissing J
Muscle Nerve; 2013 Mar; 47(3):409-15. PubMed ID: 23169601
[TBL] [Abstract][Full Text] [Related]
33. Cerebral and muscle MRI abnormalities in myotonic dystrophy.
Franc DT; Muetzel RL; Robinson PR; Rodriguez CP; Dalton JC; Naughton CE; Mueller BA; Wozniak JR; Lim KO; Day JW
Neuromuscul Disord; 2012 Jun; 22(6):483-91. PubMed ID: 22290140
[TBL] [Abstract][Full Text] [Related]
34. Effects of CTG trinucleotide repeat expansion in leukocytes on quantitative muscle histopathology in myotonic dystrophy.
Tohgi H; Utsugisawa K; Kawamorita A; Yamagata M; Saitoh K; Hashimoto K
Muscle Nerve; 1997 Feb; 20(2):232-4. PubMed ID: 9040665
[No Abstract] [Full Text] [Related]
35. Correlation among subcortical white matter lesions, intelligence and CTG repeat expansion in classic myotonic dystrophy type 1.
Kuo HC; Hsieh YC; Wang HM; Chuang WL; Huang CC
Acta Neurol Scand; 2008 Feb; 117(2):101-7. PubMed ID: 18184345
[TBL] [Abstract][Full Text] [Related]
36. Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway.
Vignaud A; Ferry A; Huguet A; Baraibar M; Trollet C; Hyzewicz J; Butler-Browne G; Puymirat J; Gourdon G; Furling D
Neuromuscul Disord; 2010 May; 20(5):319-25. PubMed ID: 20346670
[TBL] [Abstract][Full Text] [Related]
37. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.
Merlini L; Sabatelli P; Columbaro M; Bonifazi E; Pisani V; Massa R; Novelli G
Muscle Nerve; 2005 Jun; 31(6):764-7. PubMed ID: 15704146
[TBL] [Abstract][Full Text] [Related]
38. [Molecular and genetic aspects of the myotonic conditions].
Morales Montero F; Cuenca Berger P
Rev Neurol; 2004 Apr 1-15; 38(7):668-74. PubMed ID: 15098190
[TBL] [Abstract][Full Text] [Related]
39. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2).
Day JW; Roelofs R; Leroy B; Pech I; Benzow K; Ranum LP
Neuromuscul Disord; 1999 Jan; 9(1):19-27. PubMed ID: 10063831
[TBL] [Abstract][Full Text] [Related]
40. [Myotonic dystrophy].
Hara K; Sunada Y
Ryoikibetsu Shokogun Shirizu; 2000; (32):368-70. PubMed ID: 11212747
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
